| IPAD-DB ID | S00077 |
| Name | Ethyl 5-amino-4-(2-chloroquinolin-3-yl)-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrano [2, 3-b]quinoline-3-carboxylate |
| Category | Synthetic compounds |
| 2D Structure |
|
| 3D Structure | |
| Molecular Formula | C 2 5 H 2 4 C l N 3 O 3 |
| Molecular Weight | 449.9 g/mol |
| IUPAC Name | ethyl 5-amino-4-(2-chloroquinolin-3-yl)-2-methyl-6, 7, 8, 9-tetrahydro-4H-pyrano[2, 3-b]quinoline-3-carboxylate |
| InChI | InChI=1S/C25H24ClN3O3/c1-3-31-25(30)19-13(2)32-24-21(22(27)15-9-5-7-11-18(15)29-24)20(19)16-12-14-8-4-6-10-17(14)28-23(16)26/h4, 6, 8, 10, 12, 20H, 3, 5, 7, 9, 11H2, 1-2H3, (H2, 27, 29) |
| InChIKey | VMVWKSQMAJRJAT-UHFFFAOYSA-N |
| Canonical SMILES | CCOC(=O)C1=C(OC2=NC3=C(CCCC3)C(=C2C1C4=CC5=CC=CC=C5N=C4Cl)N)C |
| PubChem CID | 127052674 |
| DrugBank Accession Number | - |
| CAS Registry Number | - |
| Molecular Weight(Computed by SwissADME) | 449.93 |
| Hac(Computed by SwissADME) | 32 |
| Volume(Computed by ADMETlab 2.0) | 446.381 |
| Density(Computed by ADMETlab 2.0) | 1.006 |
| nRing(Computed by ADMETlab 2.0) | 5 |
| MaxRing(Computed by ADMETlab 2.0) | 14 |
| nHet(Computed by ADMETlab 2.0) | 7 |
| fChar(Computed by ADMETlab 2.0) | 0 |
| nRig(Computed by ADMETlab 2.0) | 29 |
| Flexibility(Computed by ADMETlab 2.0) | 0.138 |
| Stero Centers(Computed by ADMETlab 2.0) | 1 |
| LogS(Computed by ADMETlab 2.0) | -3.537 |
| LogD(Computed by ADMETlab 2.0) | 4.151 |
| logP(Computed by ADMETlab 2.0) | 5.319 |
| TPSA(Computed by SwissADME) | 87.33 |
| Hbond Acceptor(Computed by SwissADME) | 5 |
| Hbond Donor(Computed by SwissADME) | 1 |
| Rotatable Bonds(Computed by SwissADME) | 4 |
| GI Absorption(Computed by SwissADME) | High |
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
| P-gp Substrate(Computed by SwissADME) | Yes |
| CYP1A2 Inhibitor(Computed by SwissADME) | No |
| CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
| CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
| CYP2D6 Inhibitor(Computed by SwissADME) | No |
| CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
| log Kp(Skin Permeation)(Computed by SwissADME) | -5.4 |
| Lipinski(Computed by SwissADME) | 0 |
| Ghose(Computed by SwissADME) | 0 |
| Veber(Computed by SwissADME) | 0 |
| Egan(Computed by SwissADME) | 0 |
| Muegge(Computed by SwissADME) | 1 |
| Bioavailability Score(Computed by SwissADME) | 0.56 |